EGFR and neoplasm: Although none of these tumor markers have been correlated with EGFR mutation status, CYFRA 21-1 has been shown to be useful in the prediction of TKI response in EGFR mutation patients, suggesting a potential correlation between CYFRA 21-1 and EGFR mutation status [6, 7].